NCT03320941 - A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

July 25, 2018

Study Completion Date

July 25, 2018

Conditions

Obesity

Interventions

DRUG

LIK066

LIK066 will be supplied in different doses as tablets to be taken orally daily.

DRUG

Placebo

Placebo will be supplied as tablets to be taken daily orally.

Trial Locations (24)

271 0077

Novartis Investigative Site, Matsudo

818-0036

Novartis Investigative Site, Chikushino-shi

810-0066

Novartis Investigative Site, Fukuoka

819-0006

Novartis Investigative Site, Fukuoka

807-0857

Novartis Investigative Site, Kitakyushu

674-0081

Novartis Investigative Site, Akashi

675-0101

Novartis Investigative Site, Kakogawa

231-0023

Novartis Investigative Site, Yokohama

860-0863

Novartis Investigative Site, Kumamoto

860-8039

Novartis Investigative Site, Kumamoto

600-8898

Novartis Investigative Site, Kyoto

615-8125

Novartis Investigative Site, Kyoto

850 0045

Novartis Investigative Site, Nagasaki

577-0802

Novartis Investigative Site, Higashiosaka

577-0803

Novartis Investigative Site, Higashiosaka

362-8588

Novartis Investigative Site, Ageo

332 0021

Novartis Investigative Site, Kawaguchi

359-0042

Novartis Investigative Site, Tokorozawa

Unknown

Novartis Investigative Site, Tokorozawa

192-0046

Novartis Investigative Site, Hachiōji

204-0021

Novartis Investigative Site, Kiyose

108-0075

Novartis Investigative Site, Minato-ku

141-0032

Novartis Investigative Site, Shinagawa-ku

171-0021

Novartis Investigative Site, Toshima-ku